Summary
Inhaled nitric oxide delivered to patients before and during percutaneous coronary intervention for treatment of myocardial infarction does not reduce infarct size but may enhance functional recovery in patients who also receive intracoronary or intravenous nitroglycerin. This is according to results of the Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size trial [NCT01398384].
- Critical Care
- Interventional Techniques & Devices
- Myocardial Infarction Clinical Trials
- Critical Care
- Interventional Techniques & Devices
- Myocardial Infarction
- Cardiology Clinical Trials
- Cardiology
- © 2014 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.